title: [Blood pressure monitoring in infants with hemangiomas treated with corticosteroids].
abstract: BACKGROUND
  Alarming hemangiomas can be successfully treated with corticosteroids. The risk of hypertension is poorly documented in this setting. We conducted a prospective study in infants with hemangiomas treated with orally administered prednisone.
  
  
  METHODS
  Thirty-seven patients with rapidly growing complicated hemangiomas were enrolled between January 1998 and November 1999. Steroid dosages varied from 1 mg/kg/d to 5 mg/kg/d. Blood pressure measurements were performed first twice a month, then monthly at rest with a Critikon Dynamap device. Hypertension was defined as blood pressure superior to 110/60 mmHg, and borderline if superior to 110/60 mmHg on only one or two measurements.
  
  
  RESULTS
  Increased blood pressure was found in seven infants (19 p. 100). One infant had hypertension requiring specific treatment and blood pressure was borderline on six patients at one or two occasions. Cardiac ultrasound examination was performed in five patients revealing two cases of myocardic hypertrophy, which regressed after stopping steroids and without relationship to hypertension.
  
  
  CONCLUSIONS
  Even though the definition of hypertension in still arbitrary in infants, the measurement of blood pressure is necessary when steroid therapy is given for the treatment of hemangiomas. Blood pressure measurement can be difficult in very young children and overestimation is frequent if an inadequate device is used. The exact place of cardiac ultrasound remains to be defined in the management of alarming hemangiomas.
authors.affiliation: Unité de Dermatologie Pédiatrique, Hôpital Pellegrin-enfants, 33076 Bordeaux Cedex.
authors.forename: B
authors.initials: B
authors.lastname: Thédenat
authors.forename: C
authors.initials: C
authors.lastname: Léauté-Labrèze
authors.forename: F
authors.initials: F
authors.lastname: Boralevi
authors.forename: S
authors.initials: S
authors.lastname: Roul
authors.forename: L
authors.initials: L
authors.lastname: Labbé
authors.forename: V
authors.initials: V
authors.lastname: Marlière
authors.forename: A
authors.initials: A
authors.lastname: Taïeb
mesh_terms: D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use*; D000367:Age Factors; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects*; D001795:Blood Pressure Determination; D004452:Echocardiography; D005260:Female; D006391:Hemangioma / Q000188:drug therapy*; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D017379:Hypertrophy, Left Ventricular / Q000139:chemically induced; D007223:Infant; D008297:Male; D008991:Monitoring, Physiologic; D011241:Prednisone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011446:Prospective Studies; D012878:Skin Neoplasms / Q000188:drug therapy*; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D011241:Prednisone
vernacular_title: Surveillance tensionnelle des nourrissons traités par corticothérapie générale pour un hémangiome.